We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PLX market cap is 82.55M. The company's latest EPS is USD 0.1138 and P/E is 9.84.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.62M | 9.59M | 35.08M | 10.35M | 10.49M |
| Operating Income | -2.5M | -2.46M | 20.42M | -1.89M | -5.62M |
| Net Income | -3.74M | -3.13M | 19.34M | -1.85M | -6.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54.69M | 62.9M | 38.35M | 47.64M | 65.49M |
| Operating Income | -10.72M | 2.71M | -20.46M | -13.01M | 10.46M |
| Net Income | -18.28M | -6.52M | -27.58M | -14.93M | 8.31M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 55.79M | 66.56M | 88.42M | 87.57M | 84.43M |
| Total Liabilities | 66.43M | 65.55M | 49.42M | 49.32M | 50.87M |
| Total Equity | -10.64M | 1.01M | 39M | 38.25M | 33.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.39M | 67.93M | 73.67M | 55.79M | 84.43M |
| Total Liabilities | 115.71M | 94.97M | 79.7M | 66.43M | 50.87M |
| Total Equity | -70.32M | -27.04M | -6.04M | -10.64M | 33.57M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25M | -3M | 1.98M | -4.91M | -1.32M |
| Investing | -5.04M | 4.73M | 4.51M | -16.37M | -16.71M |
| Financing | 8.24M | 14.23M | 24.67M | 24.67M | 24.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.36M | -26.11M | -10.29M | -25M | -1.32M |
| Investing | -883k | -19.95M | 18.92M | -5.04M | -16.71M |
| Financing | N/A | 46.47M | 12.08M | 8.24M | 24.67M |
| Market Cap | 82.55M |
| Price to Earnings Ratio | 9.84 |
| Price to Sales Ratio | 1.25 |
| Price to Cash Ratio | 3.46 |
| Price to Book Ratio | 2.44 |
| Dividend Yield | - |
| Shares Outstanding | 73.05M |
| Average Volume (1 week) | 299.2k |
| Average Volume (1 Month) | 484.05k |
| 52 Week Change | -43.50% |
| 52 Week High | 2.505 |
| 52 Week Low | 1.0308 |
| Spread (Intraday) | 0.17 (13.93%) |
| Company Name | Protalix BioTherapeutics Inc |
| Address |
108 w. 13th street wilmington, delaware 19801 |
| Website | https://protalix.com |
| Industry | management services (8741) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
